OpenFilings

EyePoint Pharmaceuticals, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-03-08

Time Filed13:53:26

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.3
EX-10.17
EX-10.20
EX-10.21
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-97.1
Filing on SEC Edgar